This article "Myeloid cells mediate interferon-driven resistance to immunotherapy in advanced renal cell carcinoma" is published in Immunity.

Author: Kevin Bi

Journal: Immunity

Year: 2025

Podcast type: Short

Authors are:

⦁ Kevin Bi

⦁ Soki Kashima

⦁ Sabrina Y. Camp

⦁ Kevin Meli

⦁ Eddy Saad

⦁ Breanna M. Titchen

⦁ Chris Labaki

⦁ Ziad Bakouny

⦁ Erica M. Pimenta

⦁ Jihye Park

⦁ Erin Shannon

⦁ Jingxin Fu

⦁ Sherin Xirenayi

⦁ Jack Horst

⦁ Lotus Lum

⦁ Jeffrey J. Ishizuka

⦁ Toni K. Choueiri

⦁ David A. Braun

⦁ Eliezer M. Van Allen

Affiliations:

Kevin Bi, Sabrina Y. Camp, Kevin Meli, Eddy Saad, Breanna M. Titchen, Chris Labaki, Erica M. Pimenta, Jihye Park, Erin Shannon, Jingxin Fu, Sherin Xirenayi, Eliezer M. Van Allen, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02115, USA

Kevin Bi, Sabrina Y. Camp, Kevin Meli, Eddy Saad, Breanna M. Titchen, Chris Labaki, Erica M. Pimenta, Jihye Park, Erin Shannon, Jingxin Fu, Sherin Xirenayi, Eliezer M. Van Allen, Broad Institute of Harvard and MIT, Cambridge, MA 02142, USA

Soki Kashima, Jeffrey J. Ishizuka, Toni K. Choueiri, David A. Braun, Center for Molecular and Cellular Oncology, Department of Medicine (Oncology), Yale School of Medicine, New Haven, CT, USA

Soki Kashima, Department of Urology, Akita University School of Medicine, Akita, Japan

Kevin Meli, Breanna M. Titchen, Division of Medical Sciences PhD Program in Biological and Biomedical Sciences, Harvard University, Cambridge, MA, USA

Chris Labaki, Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA

Ziad Bakouny, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA

Sherin Xirenayi, Systems, Synthetic, and Quantitative Biology Graduate Program, Harvard University, Cambridge, MA, USA

Lotus Lum, Jeffrey J. Ishizuka, Department of Immunobiology, Yale School of Medicine, New Haven, CT, USA

Jeffrey J. Ishizuka, Department of Pathology, Yale School of Medicine, New Haven, CT, USA

David A. Braun, Section of Medical Oncology, Department of Internal Medicine, Yale School of Medicine, New Haven, CT, USA